[cowboyscott]

While personally I'd like to see a reduction in obesity rates by focusing on causes (e.g., "sugar taxes" and the like), it's hard to deny the positive impact of these drugs. Obesity is such a destructive epidemic in my country (US) that I see an argument for providing these drugs either for free or at substantially reduced costs via government subsidy. Despite vaccine skepticism, free COVID vaccinations might be a model worth following.

If the public sector doesn't help, I imagine that insurance companies are doing what they can to put downward price pressure on these drugs. If I can pay x now to avoid 10x in payout costs to medical providers for obesity complications (while keeping rates the same), I'm going to take that trade (subject to actuarial data and discount rates).

[nathanyz]

While I agree on your points of the benefits, the one place who is not advocating for them is insurance. People switch insurance frequently, so there is no benefit to help this year what causes a significant disease to their customer in 10 years as that benefit will likely acrue to some other insurance company.

The insurance companies basically think 1 year at a time for drug coverage and only care about keeping you alive for that 1 year at the cheapest possible price. Long term care and planning is something medicare/medicaid may better be able to utilize in their economic model to justify coverage.